Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases
- PMID: 16220774
Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases
Abstract
Background: Fibrolamellar carcinoma, a rare variant of hepatocellular carcinoma, and focal nodular hyperplasia, a benign lesion, are rare hepatic lesions that are known to occur in young women with noncirrhotic livers. Some have suggested that fibrolamellar carcinoma might be the malignant counterpart of focal nodular hyperplasia. The coexistence of the 2 lesions is very rare.
Cases: Two cases of fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia followed long-term oral contraception, and 1 of the 2 occurred during pregnancy.
Conclusion: Distinguishing fibrolamellar carcinoma from focal nodular hyperplasia has important implications for treatment and prognosis. One should be aware of such conditions, especially in patients with a long history of oral contraception.
Similar articles
-
Hepatic adenoma and focal nodular hyperplasia.Surg Gynecol Obstet. 1991 Nov;173(5):426-31. Surg Gynecol Obstet. 1991. PMID: 1658955 Review.
-
Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.Gastroenterology. 1983 May;84(5 Pt 1):994-1002. Gastroenterology. 1983. PMID: 6299876
-
Focal nodular hyperplasia of the liver and hepatic cell adenoma in women on oral contraceptives.Hepatogastroenterology. 1980 Dec;27(6):435-40. Hepatogastroenterology. 1980. PMID: 6259038
-
Liver adenoma and focal nodular hyperplasia associated with oral contraceptives.Eur J Contracept Reprod Health Care. 2001 Dec;6(4):227-30. Eur J Contracept Reprod Health Care. 2001. PMID: 11848652
-
Hepatic tumors induced by sex steroids.Semin Liver Dis. 1984 May;4(2):147-57. doi: 10.1055/s-2008-1040654. Semin Liver Dis. 1984. PMID: 6087460 Review.
Cited by
-
Management of Diagnosis and Treatment in a Case of Fibrolamellar Carcinoma.Cancer Diagn Progn. 2021 Mar 3;1(1):23-28. doi: 10.21873/cdp.10004. eCollection 2021 Mar-Apr. Cancer Diagn Progn. 2021. PMID: 35399695 Free PMC article.
-
Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).World J Gastrointest Surg. 2017 Feb 27;9(2):61-67. doi: 10.4240/wjgs.v9.i2.61. World J Gastrointest Surg. 2017. PMID: 28289511 Free PMC article.
-
Fibrolamellar carcinoma: 2012 update.Scientifica (Cairo). 2012;2012:743790. doi: 10.6064/2012/743790. Epub 2012 Sep 23. Scientifica (Cairo). 2012. PMID: 24278737 Free PMC article. Review.
-
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.Gastrointest Cancer Res. 2013 Jan;6(1):3-9. Gastrointest Cancer Res. 2013. PMID: 23505572 Free PMC article.
-
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.Oncologist. 2020 Nov;25(11):925-e1603. doi: 10.1634/theoncologist.2020-0367. Epub 2020 May 26. Oncologist. 2020. PMID: 32400000 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical